Zeenat Qureshi Stroke Research Center, University of Minnesota, Minneapolis, Minnesota, USA.
AJNR Am J Neuroradiol. 2010 Mar;31(3):454-8. doi: 10.3174/ajnr.A2006. Epub 2010 Jan 14.
Although recanalization is the goal of thrombolysis, it is well recognized that it fails to improve outcome of acute stroke in a subset of patients. Our aim was to assess the rate of and factors associated with "futile recanalization," defined by absence of clinical benefit from recanalization, following endovascular treatment of acute ischemic stroke.
Data from 6 studies of acute ischemic stroke treated with mechanical and/or pharmacologic endovascular treatment were analyzed. "Futile recanalization" was defined by the occurrence of unfavorable outcome (mRS score of > or = 3 at 1-3 months) despite complete angiographic recanalization (Qureshi grade 0 or TIMI grade 3).
Complete recanalization was observed in 96 of 270 patients treated with IA thrombolysis. Futile recanalization was observed in 47 (49%). In univariate analysis, patients with futile recanalization were older (73 +/- 11 versus 58 +/- 15 years, P < .0001) and had higher median initial NIHSS scores (19 versus 14, P < .0001), more frequent BA occlusion (17% versus 4%, P = .049), less frequent MCA occlusion (53% versus 76%, P = .032), and a nonsignificantly higher rate of symptomatic hemorrhagic complications (2% versus 9%, P = .2). In logistic regression analysis, futile recanalization was positively associated with age > 70 years (OR, 4.4; 95% CI, 1.9-10.5; P = .0008) and initial NIHSS score 10-19 (OR, 3.8; 95% CI, 1.7-8.4; P = .001), and initial NIHSS score > or = 20 (OR, 64.4; 95% CI, 28.8-144; P < .0001).
Futile recanalization is a relatively common occurrence following endovascular treatment, particularly among elderly patients and those with severe neurologic deficits.
尽管再通是溶栓的目标,但众所周知,在一部分患者中,它无法改善急性脑卒中的预后。我们的目的是评估血管内治疗急性缺血性脑卒中后,无临床获益的“无效再通”(再通后出现不良结局,即 mRS 评分在 1-3 个月时为>或=3 分)的发生率和相关因素。
分析了 6 项接受机械和/或药物血管内治疗的急性缺血性脑卒中研究的数据。“无效再通”定义为尽管完全血管再通(Qureshi 分级 0 级或 TIMI 分级 3 级),但仍出现不良结局(mRS 评分在 1-3 个月时为>或=3 分)。
IA 溶栓治疗的 270 例患者中,96 例完全再通。96 例患者中有 47 例(49%)出现无效再通。单因素分析显示,无效再通组患者年龄更大(73±11 岁比 58±15 岁,P<.0001),初始 NIHSS 评分中位数更高(19 分比 14 分,P<.0001),基底动脉闭塞更常见(17%比 4%,P=.049),大脑中动脉闭塞较少见(53%比 76%,P=.032),症状性出血性并发症发生率虽无统计学差异,但更高(2%比 9%,P=.2)。Logistic 回归分析显示,年龄>70 岁(OR,4.4;95%CI,1.9-10.5;P=.0008)和初始 NIHSS 评分 10-19 分(OR,3.8;95%CI,1.7-8.4;P=.001)与无效再通呈正相关,而初始 NIHSS 评分>或=20 分(OR,64.4;95%CI,28.8-144;P<.0001)与无效再通呈正相关。
血管内治疗后无效再通较为常见,尤其是在老年患者和神经功能缺损严重的患者中。